Giant cell tumor of bone

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 29, Issue 1, 2006, Pages 96-99

  Mendenhall, William M ^a,b   Zlotecki, Robert A ^a   Scarborough, Mark T ^a   Gibbs, C Parker ^a   Mendenhall, Nancy P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Giant cell tumor; Outcomes; Radiotherapy; Treatment

Indexed keywords

LIQUID NITROGEN; PHENOL; POLY(METHYL METHACRYLATE);

ALLOGRAFT; ARGON LASER; BONE SCINTISCANNING; BONE TRANSPLANTATION; BONE TUMOR; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CURETTAGE; FOLLOW UP; GIANT CELL TUMOR; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOGENESIS; PROSTHESIS; REVIEW; TREATMENT OUTCOME; ADJUVANT THERAPY; DIFFERENTIAL DIAGNOSIS; OSTEOCLASTOMA; PATHOLOGY; PROGNOSIS;

BONE NEOPLASMS; CURETTAGE; DIAGNOSIS, DIFFERENTIAL; GIANT CELL TUMOR OF BONE; HUMANS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT;

EID: 33644858419     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000195089.11620.b7     Document Type: Review

References (25)

1. Gamberi G, Serra M, Ragazzini P, et al. Identifications of markers of possible prognostic value in 57 giant cell tumors of bone. Oncol Reports. 2003;10:351-356.
2. Miszczyk L, Wydmanski J, Spindel J. Efficacy of radiotherapy for giant cell tumor of bone: given either postoperatively or as sole treatment. Int J Radiat Oncol Biol Phys. 2001;49:1239-1242.
3. Olivera P, Perez E, Ortega A, et al. Estrogen receptor expression in giant cell tumors of the bone. Hum Pathol. 2002;33:165-169.
4. Su YP, Chen WM, Chen TH. Giant-cell tumors of bone: an analysis of 87 cases. Int Orthop. 2004;28:239-243.
5. Feigenberg SJ, Marcus RB Jr, Zlotecki RA, et al. Radiation therapy for giant cell tumors of bone. Clin Orthop. 2003;207-216.
6. Saiz P, Virkus W, Piasecki P, et al. Results of giant cell tumor of bone treated with intralesional excision. Clin Orthop Related Res. 2004;221-226.
7. Zhen W, Yaotian H, Songjian L, et al. Giant-cell tumour of bone. The long-term results of treatment by curettage and bone graft. J Bone Joint Surg Br. 2004;86-B:212-216.
8. Campanacci M, Baldini N, Boriani S, et al. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69:106-114.
9. Stacy GS, Peabody TD, Dixon LB. Mimics on radiography of giant cell tumor of bone. AJR Am J Roentgenol. 2003;181:1583-1589.
10. Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res. 1986;9-24.
11. Feigenberg SJ, Marcus RB Jr, Zlotecki RA, et al. Whole-lung radiotherapy for giant cell tumors of bone with pulmonary metastases. Clin Orthop Relat Res. 2002;202-208.
12. Bertoni F, Bacchini P, Staals EL. Malignancy in giant cell tumor of bone. Cancer. 2003;97:2520-2529.
13. Huang L, Xu J, Wood DJ, et al. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-KB in giant cell tumor of bone. Possible involvement in tumor cell-induced osteoclastlike cell formation. Am J Pathol. 2000;156:761-767.
14. Cheng YY, Huang L, Lee KM, et al. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone. Calcif Tissue Int. 2004;75:71-77.
15. Robinson D, Segal M, Nevo Z. Giant cell tumor of bone. The role of fibroblast growth factor 3 positive mesenchymal stem cells in its pathogenesis. Pathobiology. 2003;70:333-342.
16. Nakashima H, Sugiura H, Nishida Y, et al. Stimulated type I collagen turnover in patients with giant cell tumor of bone. Calcif Tissue Int. 2003;73:5- 8.
17. Lindeman JH, Hanemaaijer R, Mulder A, et al. Cathepsin K is the principal protease in giant cell tumor of bone. Am J Pathol. 2004;165:593-600.
18. Roux S, Amazit L, Meduri G, et al. RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. Am J Clin Pathol. 2002;117:210-216.
19. Gamberi G, Benassa MS, Pompetti F, et al. Presence and expression of the Simian Virus-40 genome in human giant cell tumors of bone. Genes Chromosom Cancer. 2000;28:23-30.
20. Gamberi G, Benassi MS, Ragazzini P, et al. Proteases and interleukin-6 gene analysis in 92 giant cell tumor of bone. Ann Oncol. 2004;15:498-503.
21. Trieb K, Bitzan P, Lang S, et al. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy. Eur J Surg Oncol. 2001;27:200-202.
22. Ward WG Sr, Li G III. Customized treatment algorithm for giant cell tumor of bone: report of a series. Clin Orthop Relat Res. 2002;259-270.
23. Turcotte RE, Wunder JS, Isler MH, et al. Giant cell tumor of bone. Giant cell tumor of long bone: a Canadian Sarcoma Group Study. Clin Orthop Related Res. 2002;248-258.
24. Caudell JJ, Ballo MT, Zagars GK, et al. Radiotherapy in the management of giant cell tumor of bone. Int J Radiat Oncol Biol Phys. 2003;57:158-165.
25. Enneking WF, Dunham W, Gebhardt MC, et al. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;241-246.